Magnetoliposomes in controlled-release drug delivery systems
Critical Reviews in Biomedical Engineering, ISSN: 1943-619X, Vol: 47, Issue: 6, Page: 495-505
2019
- 12Citations
- 29Usage
- 32Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations12
- Citation Indexes12
- 12
- Usage29
- Downloads25
- Abstract Views4
- Captures32
- Readers32
- 32
- Mentions1
- News Mentions1
- 1
Most Recent News
LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy
Introduction Conventional chemotherapy usually involves the administration of drugs with side effects outside the target tissue partly because of their lack of specificity, which leads
Article Description
Liposomes, one of the most promising drug delivery carriers, have been extensively studied for the treatment of various diseases and have made their way to the market. Magnetic nanoparticles have been attracting great interest for diagnostic and therapeutic applications due to their unique magnetic properties. An integration of liposomes and magnetic nanoparticles gives great potential to the field of smart drug delivery systems, including magnetically guided drug delivery, image-guided drug delivery, and externally triggered controlled drug release using hyperthermia or alternating magnetic fields. In this review, we discuss the recent development of magnetoliposomes for controlled-release drug delivery systems and their potential.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85084857700&origin=inward; http://dx.doi.org/10.1615/critrevbiomedeng.2020033002; http://www.ncbi.nlm.nih.gov/pubmed/32421974; http://www.dl.begellhouse.com/journals/4b27cbfc562e21b8,6e3159d928ffbfcc,31bc079210a7bd2b.html; https://scholarworks.utrgv.edu/hbs_fac/169; https://scholarworks.utrgv.edu/cgi/viewcontent.cgi?article=1169&context=hbs_fac; https://dx.doi.org/10.1615/critrevbiomedeng.2020033002; https://www.dl.begellhouse.com/journals/4b27cbfc562e21b8,6e3159d928ffbfcc,31bc079210a7bd2b.html
Begell House
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know